Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

Collapse authors list.
Khanna, Dinesh, Denton, Christopher P, Jahreis, Angelika, van Laar, Jacob M, Frech, Tracy M, Anderson, Marina E, Baron, Murray, Chung, Lorinda, Fierlbeck, Gerhard, Lakshminarayanan, Santhanam et al (show 14 more authors) , Allanore, Yannick, Pope, Janet E ORCID: 0000-0003-1479-5302, Riemekasten, Gabriela, Steen, Virginia, Mueller-Ladner, Ulf, Lafyatis, Robert, Stifano, Giuseppina, Spotswood, Helen, Chen-Harris, Haiyin, Dziadek, Sebastian, Morimoto, Alyssa, Sornasse, Thierry, Siegel, Jeffrey and Furst, Daniel E (2016) Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. LANCET, 387 (10038). 2630 - 2640.

Text 101101617 SSc Ms rev FINAL Tracked.docx - Unspecified Download (7MB)

Item Type:	Article
Depositing User:	Symplectic Admin
Date Deposited:	11 May 2016 09:19
Last Modified:	19 Jan 2023 07:36
DOI:	10.1016/S0140-6736(16)00232-4
Related URLs:	Author
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3001199

Available Versions of this Item

• Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. (deposited 11 May 2016 09:19) [Currently Displayed]
  • Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. (deposited 25 Jan 2019 11:31)